A new enriched olive oil may help slow kidney damage in people with type 2 diabetes, according to a study published in Diabetes, Obesity and Metabolism. The research, conducted by Spanish institutions, tested a functional oil enriched with oleanolic acid—not the regular olive oil in your kitchen.
Type 2 diabetes is not just about blood sugar. It affects organs throughout the body, including the eyes and kidneys. Researchers are focused on finding better ways to stop or slow this damage, and this study offers a promising lead.
What the Study Actually Tested
The study included 97 patients with diabetes who took the enriched oil for 12 months alongside their usual medication. The dose was 600 mg/kg of oleanolic acid. This is a concentrated functional product, not a standard culinary oil.
Oleanolic acid is a triterpene found naturally in olive skin and leaves. Only a small fraction makes it into traditional olive oil during production. The researchers designed a product where oil acts as a vehicle to deliver this compound into the bloodstream more efficiently.
Why Regular Supermarket Olive Oil Won't Work
You might wonder if you can just drizzle more extra virgin olive oil on your salad. The answer is no. The concentration of oleanolic acid in regular olive oil is far too low to match the study's dose.
The enriched oil used in the trial was specifically formulated to deliver a therapeutic amount of oleanolic acid. Achieving the same dose through normal cooking oil would be impractical and likely impossible without consuming excessive calories.
This distinction matters. The study is not a green light to replace your cooking oil with a supplement. It is a controlled investigation of a medical food product.
Key Findings on Kidney Damage
The researchers compared patients taking the enriched oil with those taking a control. The results suggested a slowing of kidney damage markers in the enriched oil group. However, the study is not a cure, and the follow-up was limited to one year.
Kidney damage in diabetes is progressive and often silent. Finding a safe intervention that can be added to standard care is significant. But it is too early to draw firm conclusions about long-term outcomes.
- Enriched oil, not regular oil: The product contains a concentrated dose of oleanolic acid that regular olive oil cannot provide.
- Kidney protection potential: Early results suggest slower progression of kidney damage markers in diabetes patients.
- 12-month study: The trial lasted one year with 97 participants, so longer-term effects are unknown.
- Not a replacement for medication: Participants continued their usual diabetes medication throughout the study.
- Functional food category: This is a medical food, not a dietary supplement or a kitchen staple.
How This Fits into Diabetes Care
Diabetes management already includes blood sugar control, blood pressure management, and regular kidney function monitoring. Adding a functional food could become another tool in the toolbox, but only if regulatory agencies approve it and further trials confirm the benefits.
For now, patients should not seek out oleanolic acid supplements or try to mimic the study at home. The dose and formulation are specific, and self-treatment could be unsafe or ineffective. The background to this story is set out in Triple Action Diabetes Jab Slashes Blood Sugar and Weight. A related thread runs through Spain May Trigger Olive Oil Withdrawal to Stop Price Collapse. Earlier coverage in Cheffy Kitchen Kit: Squeezy Olive Oil Bottles and Pot Fillers shows how the argument developed.
Comparison of Oil Types
| Oil Type | Oleanolic Acid Content | Intended Use | Studied for Kidney Protection? |
|---|---|---|---|
| Regular olive oil (supermarket) | Low (trace amounts) | Cooking, dressing | No |
| Enriched functional oil (study product) | High (600 mg/kg dose) | Medical food under investigation | Yes, in this trial |
| Oleanolic acid supplements | Variable, unregulated | Not recommended without medical advice | No |
What to Watch Next
Larger and longer trials are needed to confirm whether the enriched oil truly protects kidneys over time. Researchers will also need to assess safety, cost, and real-world adherence. Regulatory approval would be required before any such product reaches the market. A closer look at the same subject appears in Orforglipron: The First Oral GLP-1 Pill for Weight Loss and Diabetes. Anyone following the wider picture can start with Microsnobbery Trends: Why Your Olive Oil Story Matters. The same theme surfaces in Morocco's Olive Oil Invasion Shakes Spain's Market Dominance, which takes a different angle.
In the meantime, people with diabetes should focus on proven strategies: controlling blood sugar, managing blood pressure, and getting regular kidney function tests. Discuss any new findings with your healthcare provider before making changes. Context on how this played out before sits in Microsnobbery in Food Trends: Why Olive Oil Status Matters. A companion piece, Olive Oil Price Rise Expected as Europe Crops Suffer Heat, approaches the same subject from another angle.